Metagenomi Therapeutics, Inc. · NASDAQ:MGX
Wapnick Pamela sold 1,911 Metagenomi Therapeutics, Inc. shares (Form 4)
Traded Sep 8, 2026 · Filed Sep 10, 2026
On Sep 8, 2026, Wapnick Pamela (Chief Financial Officer) sold 1,911 Metagenomi Therapeutics, Inc. shares at US$1.16 for US$2,217, leaving 206,580 shares. Filed Sep 10, 2026 (Form 4).
- Sold
- 1,911 shares
- Price
- US$1.16
- Value
- US$2,217
- Holding after
- 206,580 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 8, 2026 | Common Stock | Sale | 1,911 | US$1.16 | 206,580 | Direct |
Source
Related
- Metagenomi Therapeutics, Inc.
- Wapnick Pamela
- Metagenomi Therapeutics, Inc. shareholders
- Form 4 · Wapnick Pamela · Jun 10, 2026
- Form 4 · Wapnick Pamela · Apr 3, 2026
- Form 4 · Reid Laurence · Sep 11, 2026
- Form 4 · Wein Matthew · Sep 10, 2026
- Form 4 · Irish Jian · Sep 10, 2026
- Schedule 13G · Thomas Brian C. · Sep 10, 2026
- Form 4 · Irish Jian · Jun 10, 2026